AMGN - Amgen says FTC case to block Horizon Therapeutics deal `defies logic'
2023-08-23 11:27:44 ET
More on Amgen
- Improved Outlook For Horizon Therapeutics And Amgen
- Amgen Is Back!
- Amgen Gives You Growth, Dividend Growth, And Value
- Amgen Inc. 2023 Q2 - Results - Earnings Call Presentation
- Horizon Therapeutics gains amid speculation on potential FTC settlement on Amgen
- 2023 shaping up to be biggest year for biopharma M&A since pandemic
- Seeking Alpha’s Quant Rating on Amgen
- Earnings data for Amgen
- Dividend scorecard for Amgen
For further details see:
Amgen says FTC case to block Horizon Therapeutics deal `defies logic'